Alejandro Romero

5.7k total citations · 2 hit papers
115 papers, 4.3k citations indexed

About

Alejandro Romero is a scholar working on Molecular Biology, Pharmacology and Endocrine and Autonomic Systems. According to data from OpenAlex, Alejandro Romero has authored 115 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 35 papers in Pharmacology and 32 papers in Endocrine and Autonomic Systems. Recurrent topics in Alejandro Romero's work include Cholinesterase and Neurodegenerative Diseases (33 papers), Circadian rhythm and melatonin (31 papers) and Computational Drug Discovery Methods (14 papers). Alejandro Romero is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (33 papers), Circadian rhythm and melatonin (31 papers) and Computational Drug Discovery Methods (14 papers). Alejandro Romero collaborates with scholars based in Spain, United States and Portugal. Alejandro Romero's co-authors include János H. Fendler, Javier Egea, Eva Ramos, Manuela G. López, José Marco‐Contelles, Emilio Gil‐Martín, Cristóbal de los Rı́os, Abdelouahid Samadi, Rüssel J. Reiter and Arturo Anadón and has published in prestigious journals such as SHILAP Revista de lepidopterología, Food Chemistry and Free Radical Biology and Medicine.

In The Last Decade

Alejandro Romero

107 papers receiving 4.3k citations

Hit Papers

Liposomes as drug carriers 1977 2026 1993 2009 1977 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alejandro Romero Spain 37 1.4k 993 773 558 541 115 4.3k
Fabrice Collin France 24 1.4k 1.0× 606 0.6× 301 0.4× 480 0.9× 1.6k 3.0× 66 4.6k
Masakiyo Hosokawa Japan 39 2.5k 1.8× 1.7k 1.7× 272 0.4× 532 1.0× 918 1.7× 156 6.7k
Abdu Adem United Arab Emirates 40 2.1k 1.5× 949 1.0× 277 0.4× 329 0.6× 920 1.7× 233 6.0k
David R. Janero United States 38 2.0k 1.5× 1.4k 1.5× 774 1.0× 589 1.1× 1.1k 2.1× 127 6.8k
Seok‐Yong Lee South Korea 39 1.9k 1.4× 1.0k 1.0× 517 0.7× 474 0.8× 543 1.0× 230 5.8k
Baolu Zhao China 43 2.0k 1.5× 743 0.7× 440 0.6× 580 1.0× 1.6k 3.0× 122 6.7k
Rafael León Spain 33 1.9k 1.4× 1.2k 1.2× 1.1k 1.4× 150 0.3× 713 1.3× 83 4.2k
Javier Egea Spain 41 2.6k 1.9× 902 0.9× 460 0.6× 200 0.4× 939 1.7× 121 5.4k
Vincenzo Calderone Italy 44 2.8k 2.1× 427 0.4× 1.1k 1.4× 601 1.1× 1.2k 2.2× 258 6.9k
Silvana Hrelia Italy 47 2.9k 2.1× 601 0.6× 579 0.7× 607 1.1× 1.2k 2.1× 194 7.0k

Countries citing papers authored by Alejandro Romero

Since Specialization
Citations

This map shows the geographic impact of Alejandro Romero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Romero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Romero more than expected).

Fields of papers citing papers by Alejandro Romero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Romero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Romero. The network helps show where Alejandro Romero may publish in the future.

Co-authorship network of co-authors of Alejandro Romero

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Romero. A scholar is included among the top collaborators of Alejandro Romero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Romero. Alejandro Romero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romero, Alejandro, et al.. (2024). Dental evidence of textile-related task activities in the Bronze Age site of Laderas del Castillo (Alicante, Spain). Journal of Archaeological Science Reports. 60. 104818–104818. 1 indexed citations
2.
Öngoren, Baris, Aytug Kara, Luca Casettari, et al.. (2024). Leveraging 3D-printed microfluidic micromixers for the continuous manufacture of melatonin loaded SNEDDS with enhanced antioxidant activity and skin permeability. International Journal of Pharmaceutics. 663. 124536–124536. 9 indexed citations
3.
Romero, Alejandro, Gianluca Baldassarre, Richard J. Duro, & Vieri Giuliano Santucci. (2024). Autonomous Discovery and Learning of Interdependent Goals in Non-Stationary Scenarios. 1–8.
4.
Jiménez, Victoria, Eva Ramos, Adán Hernández, et al.. (2023). Non-Excitatory Amino Acids, Melatonin, and Free Radicals: Examining the Role in Stroke and Aging. Antioxidants. 12(10). 1844–1844. 12 indexed citations
5.
Palomino‐Antolín, Alejandra, Víctor Farré‐Alins, Ana Belén López-Rodríguez, et al.. (2023). Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4. Antioxidants. 12(9). 1729–1729. 5 indexed citations
6.
Reiter, Rüssel J., Ramaswamy Sharma, Alejandro Romero, et al.. (2023). Aging-Related Ovarian Failure and Infertility: Melatonin to the Rescue. Antioxidants. 12(3). 695–695. 31 indexed citations
7.
López‐Muñoz, Francisco, et al.. (2022). Role of serendipity in the discovery of classical antidepressant drugs: Applying operational criteria and patterns of discovery. World Journal of Psychiatry. 12(4). 588–602. 5 indexed citations
8.
Ramos, Eva, Francisco López‐Muñoz, Emilio Gil‐Martín, et al.. (2021). The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy. Antioxidants. 10(7). 1152–1152. 20 indexed citations
9.
Więckowska, Anna, Adam Bucki, Gniewomir Latacz, et al.. (2020). In Vitro and In Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases. ACS Chemical Neuroscience. 11(22). 3793–3801. 8 indexed citations
10.
Estrada, Martín, Concepción Pérez, Dolores Viña, et al.. (2019). New flavonoid –N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties. Journal of Enzyme Inhibition and Medicinal Chemistry. 34(1). 712–727. 27 indexed citations
11.
Estrada, Martín, Concepción Pérez, José Á. Morales-García, et al.. (2018). Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease. European Journal of Medicinal Chemistry. 156. 534–553. 40 indexed citations
12.
Ramos, Eva, et al.. (2018). Melatonin: A hypothesis for Kawasaki disease treatment. Medical Hypotheses. 119. 6–10. 3 indexed citations
13.
Estrada, Martín, Concepción Pérez, Dolores Viña, et al.. (2016). New cinnamic – N-benzylpiperidine and cinnamic – N,N-dibenzyl(N-methyl)amine hybrids as Alzheimer-directed multitarget drugs with antioxidant, cholinergic, neuroprotective and neurogenic properties. European Journal of Medicinal Chemistry. 121. 376–386. 45 indexed citations
14.
Romero, Alejandro, Eva Ramos, María Jesús Oset‐Gasque, et al.. (2016). Melatonin and Nitrones As Potential Therapeutic Agents for Stroke. Frontiers in Aging Neuroscience. 8. 281–281. 10 indexed citations
15.
Romero, Alejandro, Eva Ramos, Irma Arés, et al.. (2016). Fipronil sulfone induced higher cytotoxicity than fipronil in SH-SY5Y cells: Protection by antioxidants. Toxicology Letters. 252. 42–49. 63 indexed citations
16.
Chioua, Mourad, Marta Pérez, Óscar M. Bautista‐Aguilera, et al.. (2015). Development of HuperTacrines as Non-Toxic, Cholinesterase Inhibitors for the Potential Treatment of Alzheimer’s Disease. Mini-Reviews in Medicinal Chemistry. 15(8). 648–658. 10 indexed citations
17.
Wang, Li, Gerard Esteban, Óscar M. Bautista‐Aguilera, et al.. (2014). Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 80. 543–561. 127 indexed citations
18.
Klimek, Virginia M., Michael Tees, Sean M. Devlin, et al.. (2012). Efficacy of hypomethylating agents in therapy-related myelodysplastic syndromes. Leukemia Research. 36(9). 1093–1097. 25 indexed citations
19.
Chabchoub, Fakher, María Jesús Oset‐Gasque, María Pilar González, et al.. (2012). Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 54. 750–763. 67 indexed citations
20.
Lafuente, A., et al.. (2003). Effect of cadmium on lymphocyte subsets distribution in thymus and spleen. Journal of Physiology and Biochemistry. 59(1). 43–48. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026